Chronic effects of selective endothelin ETA or ETB receptor antagonist on cardiac dysfunction in the J-2-N cardiomyopathic hamsters

被引：0
|
作者：
Nishida, M
Hayashi, T
Ieshima, M
Eshiro, K
Akiyoshi, K
Takaoka, M
Matsumura, Y
机构：
[1] Osaka Univ Pharmaceut Sci, Dept Pharmacol, Osaka 5691094, Japan
[2] Osaka Med Coll, Dept Med 3, Takatsuki, Osaka 5691094, Japan
来源：
JAPANESE JOURNAL OF PHARMACOLOGY | 2002年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P795
引用
收藏
页码：260P / 260P
页数：1
相关论文
共 50 条
  • [41] Effects of bosentan, a mixed ETA-ETB receptor antagonist on cardiac metabolism and infarct size in a feline model of myocardial ischemia and reperfusion injury
    Gupta, SK
    Arya, DS
    Singh, U
    Gupta, YK
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R614 - R614
  • [42] The effects of ET-1 and YM598, a novel selective endothelin ETA receptor antagonist, on the lower urinary tract
    Yuyama, H
    Fujimori, A
    Koakutsu, A
    Sanagi, M
    Ukai, M
    Ohtake, A
    Sato, S
    Sudoh, K
    Sasamata, M
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 252P - 252P
  • [43] Chronic effects of an orally active selective endothelin-B-receptor antagonist in experimental congestive heart failure
    Sawaki, M
    Wada, A
    Tsutamoto, T
    Ohnishi, M
    Fujii, M
    Matsumoto, T
    Kinoshita, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 : S323 - S326
  • [44] Differential modulation of the renal and myocardial endothelin system by angiotensin II in vivo -: Effects of chronic selective ETA receptor blockade
    Barton, M
    Shaw, S
    d'Uscio, LV
    Moreau, P
    Lüscher, TF
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S265 - S268
  • [45] A novel and selective endothelin ETA receptor antagonist YM598 prevents the development of chronic hypoxia-induced pulmonary hypertension in rats
    Yuyama, H
    Fujimori, A
    Sanagi, M
    Koakutsu, A
    Noguchi, Y
    Sudoh, K
    Sasamata, M
    Miyata, K
    VASCULAR PHARMACOLOGY, 2005, 43 (01) : 40 - 46
  • [46] Distinct cardiac and renal effects of ETA receptor antagonist and ACE inhibitor in experimental type 2 diabetes
    Zoja, Carla
    Cattaneo, Sara
    Fiordaliso, Fabio
    Lionetti, Vincenzo
    Zambelli, Vanessa
    Salio, Monica
    Corna, Daniela
    Pagani, Chiara
    Rottoli, Daniela
    Bisighini, Cinzia
    Remuzzi, Giuseppe
    Benigni, Ariela
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2011, 301 (05) : F1114 - F1123
  • [47] The effects of endothelin-1 and YM598, a novel selective endothelin ETA receptor antagonist, on the lower urinary tract in vitro (rabbit tissue) and in vivo (dogs).
    Yuyama, H
    Fujimori, A
    Koakutsu, A
    Sanagi, M
    Ukai, M
    Ohtake, A
    Sato, S
    Sudoh, K
    Sasamata, M
    JOURNAL OF UROLOGY, 2005, 173 (04): : 392 - 392
  • [48] Effects of chronic administration of the novel endothelin antagonist J-104132 on endothelial dysfunction in streptozotocin-induced diabetic rat
    Kanie, N
    Kamata, K
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (08) : 1935 - 1942
  • [49] Effects of endothelin ETA receptor blocker LU 135252 on cardiac remodeling and survival in a hypertensive rat model of chronic heart failure
    Qin-gui Xia
    Alexander Reinecke
    Marc Dorenkamp
    Mat Jap Daemen
    Reichiger Simon
    Thomas Unger
    Acta Pharmacologica Sinica, 2006, 27 : 1417 - 1422
  • [50] Effects of endothelin ETA receptor blocker LU 135252 on cardiac remodeling and survival in a hypertensive rat model of chronic heart failure
    Xia, Qin-gui
    Reinecke, Alexander
    Dorenkamp, Marc
    Daemen, Mat Jap
    Simon, Reichiger
    Unger, Thomas
    ACTA PHARMACOLOGICA SINICA, 2006, 27 (11) : 1417 - 1422
12345